Your browser doesn't support javascript.
loading
Sensitivity and specificity of Monte Carlo based independent secondary dose computation for detecting modulation-related dose errors in intensity modulated radiotherapy.
Kowatsch, Matthias; Szeverinski, Philipp; Clemens, Patrick; Künzler, Thomas; Söhn, Matthias; Alber, Markus.
Afiliación
  • Kowatsch M; Institute of Medical Physics, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800 Feldkirch, Austria. Electronic address: matthias.kowatsch@lkhf.at.
  • Szeverinski P; Institute of Medical Physics, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800 Feldkirch, Austria.
  • Clemens P; Department of Radio-Oncology, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800 Feldkirch, Austria.
  • Künzler T; Institute of Medical Physics, Academic Teaching Hospital Feldkirch, Carinagasse 47, 6800 Feldkirch, Austria.
  • Söhn M; Scientific-RT GmbH, Welserstr. 7, 81373 München, Germany.
  • Alber M; Department of Radiation Oncology, Heidelberg University Hospital, Im Neuenheimer Feld 400, 69120 Heidelberg, Germany; Heidelberg Institute for Radiation Oncology (HIRO), Im Neuenheimer Feld 400, 69120 Heidelberg, Germany; Scientific-RT GmbH, Welserstr. 7, 81373 München, Germany.
Z Med Phys ; 2023 Oct 25.
Article en En | MEDLINE | ID: mdl-37891103
ABSTRACT

BACKGROUND:

The recent availability of Monte Carlo based independent secondary dose calculation (ISDC) for patient-specific quality assurance (QA) of modulated radiotherapy requires the definition of appropriate, more sensitive action levels, since contemporary recommendations were defined for less accurate ISDC dose algorithms.

PURPOSE:

The objective is to establish an optimum action level and measure the efficacy of a Monte Carlo ISDC software for pre-treatment QA of intensity modulated radiotherapy treatments.

METHODS:

The treatment planning system and the ISDC were commissioned by their vendors from independent base data sets, replicating a typical real-world scenario. In order to apply Receiver-Operator-Characteristics (ROC), a set of treatment plans for various case classes was created that consisted of 190 clinical treatment plans and 190 manipulated treatment plans with dose errors in the range of 1.5-2.5%. All 380 treatment plans were evaluated with ISDC in the patient geometry. ROC analysis was performed for a number of Gamma (dose-difference/distance-to-agreement) criteria. QA methods were ranked according to Area under the ROC curve (AUC) and optimum action levels were derived via Youden's J statistics.

RESULTS:

Overall, for original treatment plans, the mean Gamma pass rate (GPR) for Gamma(1%, 1 mm) was close to 90%, although with some variation across case classes. The best QA criterion was Gamma(2%, 1 mm) with GPR > 90% and an AUC of 0.928. Gamma criteria with small distance-to-agreement had consistently higher AUC. GPR of original treatment plans depended on their modulation degree. An action level in terms of Gamma(1%, 1 mm) GPR that decreases with modulation degree was the most efficient criterion with sensitivity = 0.91 and specificity = 0.95, compared with Gamma(3%, 3 mm) GPR > 99%, sensitivity = 0.73 and specificity = 0.91 as a commonly used action level.

CONCLUSIONS:

ISDC with Monte Carlo proves highly efficient to catch errors in the treatment planning process. For a Monte Carlo based TPS, dose-difference criteria of 2% or less, and distance-to-agreement criteria of 1 mm, achieve the largest AUC in ROC analysis.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Z Med Phys Asunto de la revista: RADIOTERAPIA Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Z Med Phys Asunto de la revista: RADIOTERAPIA Año: 2023 Tipo del documento: Article